# Agomelatine

## Valdoxan 25mg

| TAH Drug Code      | [OVALD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OVALD)                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment for adult patients with major depression and generalized anxiety disorder.                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Generally， take 25mg orally before bedtime. Treatment should last at least 6 months to ensure symptom resolution. Dose adjustment: If no improvement， increase the dose to 50mg at bedtime. 1) For depression: After 2 weeks of initial treatment. 2) For generalized anxiety disorder: After 4 weeks of initial treatment.                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Concomitant use of potent CYP1A2 inhibitors. Hepatic impairment (ie， cirrhosis or active liver disease) or transaminase levels greater than 3 times ULN. Hypersensitivity to agomelatine or any component of the product..                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Common: Hyperhidrosis (0.1% to <1%)， Abdominal pain (1% to <10%)， Constipation (1% to <10%)， Diarrhea (1% to <10%)， Nausea (1% to <10%)， Vomiting (1% to <10%)， Backache (1% to <10%)， Dizziness (1% to <10%)， Headache (>=10%)， Insomnia (1% to <10%)， Migraine (0.1% to <1%)， Somnolence (1% to <10%)， Anxiety (1% to <10%)， Fatigue (1% to <10%) Serious: Hepatitis (0.01% to <0.1%)， Jaundice (0.01% to <0.1%)， Liver failure (0.01% to <0.1%)， Hallucinations (0.01% to <0.1%) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/agomelatine-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                    |

